Renovo News
-
INTERIM MANAGEMENT STATEMENT...en lire plus
-
LANCET PUBLICATION OF JUVISTA® (INN: AVOTERMIN) TRIAL RESULTS FOR THE IMPROVEMENT OF SKIN SCARRING ...en lire plus
-
Renovo Group plc (LSE: RNVO), the biopharmaceutical company developing drugs for the reduction of scarring and acceleration of healing is pleased to announce, with immediate effect, the appointment...en lire plus
-
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Renovo Group plc 2....en lire plus
-
Details of the RNS detailing the revised Shire licensing deal for Juvista can be viewed here ...en lire plus
-
Details of the outcome of the 2010 AGM are here...en lire plus
-
PRELIMINARY RESULTS NOTIFICATION ...en lire plus